BFG
GSK icon

Bleakley Financial Group’s GSK GSK Stock Holding History

Bleakley Financial Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14M Buy
40,749
+8,048
+25% +$426K 0.03% 452
2026
Q1 		$1.8M Sell
32,701
-3,523
-10% -$191K 0.03% 409
2025
Q4 		$1.78M Buy
36,224
+5,537
+18% +$258K 0.03% 377
2025
Q3 		$1.32M Buy
30,687
+7,885
+35% +$308K 0.03% 358
2025
Q2 		$876K Buy
+22,802
New +$871K 0.02% 417

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bleakley Financial Group's GSK Position: Q2 2026 in Review

Bleakley Financial Group increased its GSK (GSK) stake by 25% in Q2 2026, buying an estimated $426K and bringing the position to 40,749 shares worth $2.14M. The position accounts for 0.03% of the portfolio, ranked #452.

Bleakley Financial Group first reported a position in GSK in Q2 2025 and has held it in 5 quarters since. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Bleakley Financial Group held 40,749 shares of GSK worth $2.14M as of Q2 2026.
  • Bleakley Financial Group bought 8,048 GSK shares in Q2 2026, an estimated $426K.
  • GSK made up 0.03% of Bleakley Financial Group's portfolio in Q2 2026, its #452 holding.
  • Bleakley Financial Group first reported a position in GSK in Q2 2025 and has held it in 5 quarters since.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.